“Ken Bonnell is one of the most accomplished and respected top executives in QA and compliance, and he brings with him a solid track record, superb leadership skills, and a keen understanding of the regulatory issues and challenges that biosciences companies face,” said Tara Kochis-Stach.
SOUTH RIDING, Va. (PRWEB)
September 09, 2020
Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Kenneth Bonnell as Vice President of Quality and Regulatory Affairs at Aldevron. Bonnell will join the company’s executive team, and in addition to overseeing quality and regulatory compliance, will supervise standards across all of Aldevron’s operations sites.
Bonnell is an accomplished quality, operations, and regulatory compliance expert with more than two decades of experience in the biosciences, biotech, and pharmaceutical industries. Most recently, he served as the Vice President and Global Head of Quality for Teligent Pharma, a multi-million dollar global pharmaceutical company, where he was responsible for returning the organization to a state of compliance following an FDA warning letter. He also spent five years at Merck, where he served as Director of Quality Assurance, and six years at PCI Pharma, where he served as Executive Director of QA, and later as Global Vice President of Quality and Regulatory Affairs.
Founded in 1998, Aldevron is the leading global supplier of GMP, GMP-Source™, and Research Grade plasmid DNA used in commercial, clinical, and research stage gene therapies, as well as proteins, antibodies, and mRNA. The company’s custom development and manufacturing capabilities enable scientists worldwide to develop groundbreaking new therapies with a focus on quality, speed, and innovation.
“Ken Bonnell is one of the most accomplished and respected top executives in QA and compliance, and he brings with him a solid track record, superb leadership skills, and a keen understanding of the regulatory issues and challenges that biosciences companies face. He will be an excellent addition to the Aldevron management team, and Slone Partners was honored to have partnered with the company to place him,” said Slone Partners President Tara Kochis-Stach.
“Ken is a rare industry expert on biotechnology, pharmaceuticals, and medical device regulatory compliance, standards, and quality assurance,” said Marc Wolff, Aldevron’s Chief Financial Officer and Chief Operating Officer. “His work ethic, team-based approach, and dedication to delivering the best outcome for our clients, make him the optimal fit on the biomanufacturing team.”
“Aldevron has a distinguished reputation for the highest quality products and services,” said Bonnell. “I look forward to building upon and strengthening that reputation by reviewing all currently established procedures and implementing process improvements, maintaining rigorous compliance and regulatory standards, and further supporting our clients’ approval processes.”
Bonnell graduated with a B.S. degree in Biology from Mary Washington University, Fredericksburg, VA; and an M.B.A. in Business Management from Montgomery University, Meridian, MS; and a Master of Science in Biology from the University of Nebraska, Kearney, NE.
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing scientific healthcare organizations – People Are Our Science®. Since 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established life sciences, biotech, diagnostics, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, New York, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services to innovative scientific healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins, and antibodies. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from research grade to clinical trials to commercial applications. Aldevron specializes in GMP manufacturing and is known for inventing the GMP-Source® quality system. Company headquarters are in Fargo, N.D., with additional facilities in Madison, WI, and Freiburg, Germany. For more information visit https://www.aldevron.com.
Share article on social media or email: